Skip to content

Clinical trials

Completed Pseudomonas Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pseudomonas Infections Status: Completed Country / region: United States Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20043
20053
20085
20093
20101
20114
20123
20131
20143
20151
20162
20172
20201
20211
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences9
National Heart, Lung, and Blood Institute (NHLBI)3
Aradigm Corporation2
Armata Pharmaceuticals, Inc.2
Bayer2
Humanigen, Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2
Aridis Pharmaceuticals, Inc.1
Bonnie Ramsey1
CF Therapeutics Development Network Coordinating Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pseudomonas Infections43
Cystic Fibrosis29
Pneumonia3
Bacteremia2
Lung Diseases2
Respiratory Aspiration2
Respiratory Tract Infections2
Bronchiectasis1
Bronchiolitis Obliterans Syndrome1
Bronchitis, Chronic1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.